Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparin-binding pro-inflammatory chemokines and cytokines are a functional group of signaling proteins that play a critical role in the orchestration of the inflammatory response. These molecules, which include Interleukin-8 (CXCL8), Monocyte Chemoattractant Protein-1 (CCL2), and RANTES (CCL5), possess specific basic amino acid clusters that allow them to bind to heparin and heparan sulfate proteoglycans (HSPGs) on cell surfaces and within the extracellular matrix [1, 4]. This interaction is essential for the formation of stable haptotactic gradients, which guide the migration of leukocytes to sites of injury or infection, and for protecting these cytokines from proteolytic degradation [2, 5]. In pathological conditions such as sepsis, rheumatoid arthritis, and cancer, the dysregulated expression of these heparin-binding mediators leads to excessive tissue infiltration by immune cells and chronic inflammation [3]. Therapeutic interventions targeting this class include heparin mimetics, such as Pixatimod, and specialized filtration devices like CytoSorb, which sequester these proteins to prevent their interaction with signaling receptors and HSPGs, thereby dampening the systemic inflammatory response [3, 5]. Citations: [1] Proudfoot, A. E. I. (2006). Biochemical Society Transactions. [2] Ori, A., et al. (2011). Frontiers in Bioscience. [3] Dredge, K., et al. (2010). British Journal of Cancer. [4] Parish, C. R. (2006). Immunology and Cell Biology. [5] Grissom, C. K., et al. (2021). Critical Care Explorations.
These agents typically act by sequestering pro-inflammatory mediators through their heparin-binding domains or by competitively inhibiting the interaction between these mediators and cell-surface heparan sulfate proteoglycans (HSPGs), thereby preventing receptor activation and the formation of chemotactic gradients.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparin-binding pro-inflammatory chemokines and cytokines.